Recursion Pharmaceuticals Inc Cl A (RXRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -248,509 | -117,504 | -644,759 | -536,637 | -374,384 |
| Depreciation Amortization | 37,840 | 19,673 | 83,701 | 64,223 | 43,180 |
| Income taxes - deferred | -4,600 | -4,597 | N/A | N/A | 219 |
| Accounts receivable | 8,454 | 14,746 | N/A | 33,775 | 30,246 |
| Accounts payable and accrued liabilities | -5,602 | 2,070 | -2,616 | -7,035 | -1,145 |
| Other Working Capital | -26,365 | -7,805 | 13,688 | 3,005 | 29,301 |
| Other Operating Activity | 51,734 | 12,316 | 178,178 | 116,934 | 64,208 |
| Operating Cash Flow | $-187,048 | $-81,101 | $-371,808 | $-325,735 | $-208,375 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | -3,806 | -3,806 | -1,500 |
| PPE Investments | -302 | -258 | -6,469 | -5,225 | -4,982 |
| Net Acquisitions | N/A | N/A | -4,438 | -4,438 | -4,438 |
| Purchase Sale Intangibles | -1,995 | -80 | -2,158 | -2,158 | -2,158 |
| Other Investing Activity | -1,995 | -80 | -2,158 | -2,158 | -2,158 |
| Investing Cash Flow | $-2,297 | $-338 | $-16,871 | $-15,627 | $-13,078 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -4,459 | -2,208 | -8,425 | -6,258 | -4,131 |
| Common Stock Issued | 0 | 0 | 528,864 | 395,484 | 141,024 |
| Other Financing Activity | -278 | -1,262 | 1,093 | 300 | 1,293 |
| Financing Cash Flow | $-4,737 | $-3,470 | $521,532 | $389,526 | $138,186 |
| Exchange Rate Effect | -3,019 | -3,832 | 18,044 | 15,957 | 14,088 |
| Beginning Cash Position | 753,921 | 753,921 | 603,024 | 603,024 | 603,024 |
| End Cash Position | 556,820 | 665,180 | 753,921 | 667,145 | 533,845 |
| Net Cash Flow | $-197,101 | $-88,741 | $150,897 | $64,121 | $-69,179 |
| Free Cash Flow | |||||
| Operating Cash Flow | -187,048 | -81,101 | -371,808 | -325,735 | -208,375 |
| Capital Expenditure | -302 | -258 | -6,469 | -5,225 | -4,982 |
| Free Cash Flow | -187,350 | -81,359 | -378,277 | -330,960 | -213,357 |